OTHR-13. Effectivity and toxicity of off-label treatment with Trametinib monotherapy or in combination with Dabrafenib in children with relapsed or refractory brain tumor von Bregonje, S (Selena), de Vos-Kerkhof, E (Evelien), Engels, F K (Frederike), van Veelen, M L C (Marie-Lise), van der Lugt, J (Jasper)

Volltext

Docetaxel administration schedule: From fever to tears? A review of randomised studies von Engels, Frederike K., Verweij, Jaap

Volltext

Effect of Cytochrome P450 3A4 Inhibition on the Pharmacokinetics of Docetaxel von Engels, Frederike K., Tije, Albert J., Baker, Sharyn D., Lee, Carlton K. K., Loos, Walter J., Vulto, Arnold G., Verweij, Jaap, Sparreboom, Alex

Volltext

Medicinal cannabis in oncology practice: still a bridge too far? von de Jong, Floris A, Engels, Frederike K, Mathijssen, Ron H J, van Zuylen, Lia, Verweij, Jaap, Peters, Remco P H, Sparreboom, Alex

Volltext